New Zealand markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
67.24+0.25 (+0.37%)
At close: 4:00PM EDT
67.30 +0.06 (+0.09%)
After hours: 07:36PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close66.99
Open67.12
Bid66.51 x 1800
Ask67.31 x 4000
Day's range66.51 - 67.27
52-week range56.56 - 73.34
Volume4,501,244
Avg. volume6,198,975
Market cap84.306B
Beta (5Y monthly)0.42
PE ratio (TTM)16.46
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.84 (4.22%)
Ex-dividend date14 Sep 2021
1y target estN/A
  • Motley Fool

    2 High-Yielding Stocks You Can Buy and Hold for Years

    If you're investing in a dividend stock, it's important to balance yield with risk. While you don't want to be too aggressive by looking for 10% dividend yields, you don't want to settle for nominal payouts either. Two stocks that pay at least 3% and are fairly safe buys over the long haul are Gilead Sciences (NASDAQ: GILD) and Campbell Soup (NYSE: CPB).

  • Motley Fool

    Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?

    Earlier this month, Merck (NYSE: MRK) announced it was ending clinical trials of its antiviral pill candidate for treating COVID-19, molnupiravir, on account of the potential therapy's high level of effectiveness. Take Gilead Sciences' (NASDAQ: GILD) antiviral drug, remdesivir. Will Merck's drug follow a similar or better path?

  • Zacks

    Gilead Sciences (GILD) Gains As Market Dips: What You Should Know

    Gilead Sciences (GILD) closed the most recent trading day at $67.24, moving +0.37% from the previous trading session.